SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?


To: Dan Spillane who wrote (1204)2/17/1999 10:36:00 AM
From: Anthony Wong  Respond to of 2539
 
02/17 09:24 Monsanto says British public will accept GM food

LONDON, Feb 17 (Reuters) - British public opinion will accept that
biotechnology offers valuable benefits once the current controversy
over genetic modification dies down, U.S. chemicals giant Monsanto
Co <MTC.N> said on Wednesday.

Tom McDermott, responsible for public affairs for Monsanto in Europe,
accepted a British court's judgement earlier over breaches of
environmental rules at an experimental crop site, but stressed that
there was no danger involved.

"The sole purpose of this trial was to assess the commercial viability
of the crop," he said. "It had already gone through all the environmental
checks."

Monsanto was on Wednesday found guilty of breaching environmental
regulations at a test site for genetically modified (GM) crops in eastern
England and was fined 17,000 pounds.

There has been renewed concern recently over the safety of GM
foods, sparked when scientists from Britain, Europe, the United States
and Canada came out in support of British-based scientist Arpad
Pusztai.

Pusztai was forced to retire last year after he said his experiments
showed GM potatoes could damage rats' vital organs.

McDermott pointed to the adoption of earlier technologies as showing
how the GM debate was likely to go.

"Often new technology experiences a period of public debate, even
with a slight tinge of hysteria."

"However, when the technology does have benefits it usually prevails,"
he said.

"The discussion in the UK today is not helping anyone to make up their
mind."

moneynet.com\Company&Index=0&ID=SF-02/17-AnG17152129@NEWS-P2



To: Dan Spillane who wrote (1204)2/17/1999 10:45:00 AM
From: Anthony Wong  Respond to of 2539
 
Argentina May Delay Approval of Monsanto's Modified Corn Seed

Bloomberg News
February 17, 1999, 7:54 a.m. ET

Buenos Aires, Feb. 17 (Bloomberg) -- Argentina may delay the
approval of Monsanto Co.'s genetically modified corn for use by
the country's farmers, reported newspaper Buenos Aires Economico.
While the company's Roundup Ready corn seed has passed all of
Argentina's technical tests, the agriculture department still
hasn't ruled on the sale of the seed because the altered crop
faces opposition from consumers in Europe, a buyer of Argentine
corn. Argentine Agriculture Secretary Gumersindo Alonso will rule
on the recommendations of his office's markets department, though
no time line was given, the report said.

Analysts expect Argentina, the world's biggest corn exporter
after the U.S., to produce about 14.5 million tons of corn, down
25 percent from last year's record crop of 19.4 million tons
after low prices sank planting of the grain.

(Buenos Aires Economico 2/17 5)

--Susan Schneider in Buenos Aires (5411) 4321-7733 through the



To: Dan Spillane who wrote (1204)2/17/1999 10:48:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 2539
 
Monsanto Co. Raised to 'Buy' at Arnhold Bleichroeder [target $65]

Bloomberg News
February 17, 1999, 9:14 a.m. ET

Princeton, New Jersey, Feb. 17 (Bloomberg Data) -- Monsanto Co. (MTC US)
was raised to ''buy'' from ''attractive'' by analyst Richard R. Stover at
Arnhold and S. Bleichroeder Inc. The 12-month target price is $65.00 per
share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652

news.com